Skip to search formSkip to main contentSkip to account menu

Gd@C82(OH)22

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Artificial nanoparticlesFullerenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Gd-Metallofullerenol nanoparticles cause intracellular accumulation of PDGFR-α and morphology alteration of fibroblasts.
Gadolinium-metallofullerenols (Gd@C82(OH)22) are a promising agent for cancer therapy and have shown beneficial effects in… 
2018
2018
Gd@C82(OH)22 harnesses inflammatory regeneration for osteogenesis of mesenchymal stem cells through JNK/STAT3 signaling pathway.
Tissue injuries are inevitably accompanied with immune responses. Understanding the effects of biomaterials on immunology… 
Review
2015
Review
2015
Caging cancer.
  • L. Balogh
  • Nanomedicine : nanotechnology, biology, and…
  • 2015
  • Corpus ID: 207061631
2014
2014
Regulation on mechanical properties of collagen: enhanced bioactivities of metallofullerol.
2010
2010
Subcellular distribution of polyhydroxylated metallofullerene Gd@C82(OH)22 in different tissues of tumor-bearing mice.
Endohedral metallofullerenes have unique chemical and physical properties that are essential for biomedical applications. They… 
2008
2008
Eliminating active species by endohedral metallofullerenol in vitro and in vivo
We previously demonstrated that gadolinium endohedral metallofullerenol Gd@C82(OH)22 nanoparticles had high inhibitory activity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)